ARTMS Inc.: federal grants and contributions: 7 agreements; $3.0M value; 4 departments; 3 programs.
Assay record ASY-CA-03WN4UV0Q6 · Cite as: Assay Systems, “ARTMS Inc.: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/artms-inc/
Expand the use of cyclotrons for production of GMP medical isotopes
Scale-up and expand product portfolio to include three additional medical isotopes
EUREKA E!17003 Ga-68-PSMA-11 project with an Israeli partner Isotopia Molecular Imaging Ltd to develop high activity gallium-68 (Ga-68) cyclotron production for Prostate Specific Membrane Antigen (PSMA) radiopharmaceutical use and treatment monitoring in patients with prostate cancer.
Develop improved methods for the production of Zinc-68 solid target plates used in the production of high-purity and high-yield Gallium-68 diagnostic imaging isotopes.
The project will support development of intellectual property capacity within the firm.
The project will support development of intellectual property capacity within the firm.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.